Company intelligence / Profile preview

3NT Medical

Rosh Ha’ayin, Israel

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

3NT Medical has developed and commercialized single-use, maneuverable endoscopes specifically designed for ENT surgeons. Their Colibri™ Micro ENT Scope is FDA-cleared for otologic procedures, enabling minimally invasive ear surgery with two-handed operation. The Peregrine™ Drivable ENT Scope is FDA-cleared for deep intra-sinus visualization with minimal resection. Both devices are sterile and single-use to reduce infection risk. No active clinical trials are currently registered.

Therapeutic areas: OtherPulmonology
Modalities: DeviceEndoscope (single-use, maneuverable)
Industry: Surgical Medical Devices

Partnerships

Hoya Corp. (investor/strategic partner)

Beyond the preview

Go deeper on 3NT Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3NT Medical.

Explore the full profile